The continuing global loss of biodiversity is making it increasingly necessary to rapidly collect and analyze genetic ...

As part of the investment, the company opened a biomass power plant in Ingelheim, Germany, in January this year, and completed the Biologicals Development Centre in Biberach last year. A chemical ...

INGELHEIM, Germany & SOUTH SAN FRANCISCO, Calif., October 09, 2024--Boehringer Ingelheim and Circle Pharma (Circle) announce a new research collaboration and license agreement with the shared goal to ...

For years, there have been bottlenecks in the medicine supply in Europe. These have worsened in recent months in Germany. Analysts say that respite is unlikely to come any time soon.

This press release is issued from our Corporate Headquarters in Ingelheim, Germany and is intended to provide information about our global business. Please be aware that information relating to ...

In a powerful demonstration of high-level support, the World Health Organization (WHO) today received nearly US$ 700 million in new funding commitments from European countries, foundations and others, ...

Isabel Schnabel of the European Central Bank has noted that euro-zone growth excluding Germany has been “remarkably resilient” since 2021 and faster than that of many other big economies.

Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, pledged USD 5 million to advance access to quality healthcare services for ...

Advances in Therapy to Address Proteinuria in Patients with Immunoglobulin A Nephropathy. As the majority of patients with ...

A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...

(IN BRIEF) Boehringer Ingelheim and the WHO Foundation have partnered to promote equitable healthcare access and suicide prevention, with a focus on vulnerable communities in the Americas. Boehringer ...

Boehringer Ingelheim, Circle Pharma ink research collaboration to develop a novel precision cancer treatment: Ingelheim, Germany Friday, October 11, 2024, 12:00 Hrs [IST] Boehring ...